Skip to main content
Clinical Trials/ACTRN12620000385943
ACTRN12620000385943Not yet recruitingPhase 1

Clinical predictors of foot orthoses efficacy for greater trochanteric pain syndrome

a Trobe University0 sites60 target enrollmentStarted: March 20, 2020Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Non-randomised trial
Primary Purpose
Treatment
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • (i) aged 18 years or older;
  • (ii) symptoms for at least 3 months;
  • (iii) primary pain located over the lateral hip;
  • (iv) average pain intensity over the previous week of 3 or more on an 11-point numerical rating scale; and
  • (v) GTPS diagnosis confirmed via clinical assessment: (a) pain reproduced on palpation of the greater trochanter; (b) pain reproduced on the Flexion, Abduction and External Rotation (FABER) test; (c) pain on one of the following: single leg stance test, resisted hip abduction, external de-rotation test.

Exclusion Criteria

  • (i) Signs of intra-articular hip pathology; (ii) previous hip surgery on the symptomatic side; (iii) low back or other lower limb injury requiring management by a medical professional, or time off sport, work or leisure over the last three months; (iv) any neurological disorders; (v) any form of systemic arthritis; (vi) currently regularly wearing contoured shoe inserts; (vii) any foot disorder precluding wearing of shoe inserts; (viii) corticosteroid injection into hip region within previous 3 months; (x) currently undergoing treatment including physiotherapy, osteopathy or chiropractic; (ix) low-English speaking proficiency such that unable to comprehend study assessment requirements.

Investigators

Sponsor
a Trobe University

Similar Trials

Shoe inserts for lateral hip pain: The... | Clinical Trial